Tumor lysis syndrome primary prevention
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome primary prevention |
|
Risk calculators and risk factors for Tumor lysis syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Effective measures for the primary prevention of tumor lysis syndrome include allopurinol, rasburicase, and intravenous hydration.
Prevention
Before initiating chemotherapy for cancer patients, especially lymphomas and leukemias, should receive the following:
- Allopurinol
- Rasburicase (uricase) is an alternative to allopurinol and is reserved for patients who are at high-risk for developing tumor lysis syndrome.
- Adequate intravenous hydration to maintain a high urine output (> 2.5 L/day)
- Alkalinization of the urine with acetazolamide or sodium bicarbonate is controversial